Premium
Dianthus Therapeutics Inc (DNTH)
NASDAQ
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
| Actionnaire | Type | Détenues (Réel) | % en Circulation | Valeur Marchande | Date de Reporte |
|---|---|---|---|---|---|
| Point72 Associates, LLC | Institution | 2 981 674 | 5,45% | US$ 270,74M | 2026-02-13 |
| RA Capital Healthcare Fund, L.P. | Institution | 2 866 733 | 5,24% | US$ 260,30M | 2025-09-30 |
| RA Capital Management, L.P. | Institution | 2 611 733 | 4,78% | US$ 237,15M | 2026-03-31 |
| Wellington Management Group LLP | Institution | 2 595 783 | 4,75% | US$ 235,70M | 2026-03-31 |
| Fairmount Funds Management LLC | Institution | 2 537 191 | 4,64% | US$ 230,38M | 2026-03-31 |
| Fairmount Healthcare Fund II L.P. | Institution | 2 137 191 | 3,91% | US$ 194,06M | 2025-11-21 |
| Avidity Partners Management, L.P. | Institution | 2 104 184 | 3,85% | US$ 191,06M | 2026-03-31 |
| Octagon Capital Advisors LP | Institution | 1 946 667 | 3,56% | US$ 176,76M | 2026-03-31 |
| Octagon Investments Master Fund LP | Institution | 1 818 500 | 3,33% | US$ 165,12M | 2024-12-31 |
| TCG Crossover Management, LLC | Institution | 1 676 624 | 3,07% | US$ 152,24M | 2026-03-31 |
| Citadel Advisors LLC | Institution | 1 610 483 | 2,95% | US$ 146,23M | 2026-03-31 |
| TCG Crossover Fund II, L.P. | Institution | 1 501 624 | 2,75% | US$ 136,35M | 2025-03-31 |
| Bain Capital Life Sciences Fund III, L.P. | Institution | 1 315 892 | 2,41% | US$ 119,48M | 2025-09-30 |
| VR Management, LLC | Institution | 1 180 000 | 2,16% | US$ 107,14M | 2026-03-31 |
| Fred Alger Management, LLC | Institution | 1 161 923 | 2,13% | US$ 105,50M | 2026-03-31 |
| Polar Capital Holdings Plc | Institution | 1 076 009 | 1,97% | US$ 97,70M | 2026-03-31 |
| Deerfield Management Company, L.P. | Institution | 1 019 813 | 1,87% | US$ 92,60M | 2026-03-31 |
| Franklin Resources, Inc. | Institution | 961 585 | 1,76% | US$ 87,31M | 2026-03-31 |
| Cormorant Asset Management, LP | Institution | 950 000 | 1,74% | US$ 86,26M | 2026-03-31 |
| AllianceBernstein L.P. | Institution | 926 071 | 1,69% | US$ 84,09M | 2026-03-31 |
| Braidwell LP | Institution | 899 364 | 1,65% | US$ 81,66M | 2026-03-31 |
| Baker Bros. Advisors LP | Institution | 852 164 | 1,56% | US$ 77,38M | 2026-03-31 |
| UBS Asset Management AG | Institution | 841 717 | 1,54% | US$ 76,43M | 2026-03-31 |
| Farallon Capital Management, L.L.C. | Institution | 836 000 | 1,53% | US$ 75,91M | 2026-03-31 |
| Silverarc Capital Management, LLC | Institution | 654 746 | 1,20% | US$ 59,45M | 2026-03-31 |
| Point72 Asset Management, L.P. | Institution | 643 599 | 1,18% | US$ 58,44M | 2026-03-31 |
| Catalio Capital Management, LP | Institution | 560 308 | 1,02% | US$ 50,88M | 2026-03-31 |
| Jennison Associates LLC | Institution | 485 136 | 0,89% | US$ 44,05M | 2026-03-31 |
| Balyasny Asset Management L.P. | Institution | 474 085 | 0,87% | US$ 43,05M | 2026-03-31 |
| Woodline Partners LP | Institution | 433 457 | 0,79% | US$ 39,36M | 2026-03-31 |
| Samlyn Capital, LLC | Institution | 431 115 | 0,79% | US$ 39,15M | 2026-03-31 |
| MPM BioImpact LLC | Institution | 423 982 | 0,78% | US$ 38,50M | 2026-03-31 |
| Logos Global Management, L.P. | Institution | 400 000 | 0,73% | US$ 36,32M | 2026-03-31 |
| Artisan Partners Limited Partnership | Institution | 382 121 | 0,70% | US$ 34,70M | 2026-03-31 |
| Spruce Street Capital LP | Institution | 373 274 | 0,68% | US$ 33,89M | 2026-03-31 |
| Sio Capital Management, LLC | Institution | 370 045 | 0,68% | US$ 33,60M | 2026-03-31 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
